Athersys to Present at 23rd Annual Piper Jaffray Health Care Conference


CLEVELAND, Nov. 23, 2011 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that the Company is scheduled to present at the 23rd Annual Piper Jaffray Health Care Conference, to be held Tuesday, November 29 – Wednesday, November 30, 2011, at the New York Palace Hotel in New York City.

William (B.J.) Lehman, President and Chief Operating Officer, will present on Tuesday, November 29, 2011 at 4:30 p.m. Eastern Standard Time. The presentation will also be available via a live audio webcast at the following link:

http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=ATHX&item_id=4228900

Following the presentation, a replay will be available through the Athersys website at www.athersys.com under the "Investors Section" and will remain available for two weeks after the actual presentation date.

About Athersys

Athersys is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing MultiStem®, a patented, adult-derived "off-the-shelf" stem cell product platform for multiple disease indications in the cardiovascular, neurological, inflammatory and immune disease areas. The Company currently has several clinical stage programs, including for treating damage caused by myocardial infarction, bone marrow transplantation and oncology treatment support, ischemic stroke, and inflammatory bowel disease. The Company also has developed a portfolio of other therapeutic programs, including orally active pharmaceutical product candidates for the treatment of metabolic and central nervous system disorders, utilizing proprietary technologies, including Random Activation of Gene Expression (RAGE®). Athersys has forged several key strategic alliances and collaborations with leading pharmaceutical and biotechnology companies, as well as world-renowned research institutions in the United States and Europe to further develop its platform and products. More information is available at www.athersys.com.

The Athersys, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4548



            

Coordonnées